Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.68 |
| ▸ | CNR2 | P34972 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.51 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3490383 | 1.00 | CNR1 (0.68) | CNR1CNR2ALDH1A1LPAR1LPAR3 | |
| SCHEMBL3489657 | 1.00 | CNR1 (0.68) | CNR1CNR2ALDH1A1LPAR1LPAR3 | |
| SCHEMBL3489660 | 1.00 | CNR1 (0.68) | CNR1CNR2ALDH1A1LPAR1LPAR3 | |
| SCHEMBL7722123 | 0.96 | ALDH1A1 (0.60) | CNR1CNR2ALDH1A1LPAR1LPAR3 | |
| SCHEMBL1077755 | 0.90 | CNR1 (0.80) | CNR1CNR2ALDH1A1 | |
| SCHEMBL9754767 | 0.90 | CNR1 (0.80) | CNR1CNR2ALDH1A1 | |
| SCHEMBL9754773 | 0.90 | CNR1 (0.80) | CNR1CNR2ALDH1A1 | |
| SCHEMBL21753891 | 0.90 | CNR1 (0.80) | CNR1CNR2ALDH1A1 | |
| SCHEMBL18686822 | 0.90 | CNR1 (0.80) | CNR1CNR2ALDH1A1 | |
| SCHEMBL38658046 | 0.90 | CNR1 (0.80) | CNR1CNR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100076055-A1 | Cationic Lipids and Uses Thereof | ABBOTT LABORATORIES (US) | 2010-03-25 | — | — | US | disclosed |
| US-20100055169-A1 | CATIONIC LIPIDS AND USES THEREOF | ABBOTT LABORATORIES (US) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076055-A1 | Cationic Lipids and Uses Thereof | LIPA, SGMS2, SGMS1 | CNR1 3144/4885CNR2 2239/4885ALDH1A1 4724/4885 |
| US-20100055169-A1 | CATIONIC LIPIDS AND USES THEREOF | LIPA, SGMS2, SGMS1 | CNR1 3144/4885CNR2 2239/4885ALDH1A1 4724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.